Good news from the ATTLAS trial for pa... - Lung Cancer Support

Lung Cancer Support

4,067 members2,215 posts

Good news from the ATTLAS trial for patients with EGFR mutations and ALK translocations.

Denzie profile image
DenzieModeratorVolunteer
0 Replies

Treatment with atezolizumab, bevacizumab, paclitaxel, and carboplatin (ABCP) was significantly more effective than pemetrexed plus carboplatin or cisplatin

dailynews.ascopubs.org/do/a...

Written by
Denzie profile image
Denzie
Moderator
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Completed my first round of chemo and the clinical trial

Happy New Year Everyone: Just got through my first round of chemo both Carboplatin and Etoposide...
Kym105 profile image

FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression

On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...
Miranda_GO2 profile image
Partner

Out of trial

Hello everyone, bad news for me. On Jan 17th I was taken off the trial I was in. Had a very bad...
Kym105 profile image

Pemetrexed

Just started carboplatin and Pemetrexed after Keytruda failed me. Anyone familiar with Pemetrexed?...
BrigidK profile image

Opdivo

I am new here. My husband was dx with inoperable NSCLC in March 2016. Had 6 weeks of radiation and...

Moderation team

See all
AmyKamp profile image
AmyKampAdministrator
SarahMcHale profile image
SarahMcHaleAdministrator
Maureen-GO2 profile image
Maureen-GO2Administrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.